UC Berkeley scientists unveil a powerful new at-home test using nanotech and AI to detect diseases like COVID-19 and cancer with unprecedented sensitivity.
The European Union's blue economy has struggled since its setbacks during the COVID-19 pandemic but is now thriving, according to the newly released 2025 Blue Economy Report.
BioNTech, the German biopharmaceutical company behind one of the world's first COVID-19 vaccines, has announced a landmark investment of up to £1 billion in the UK over the next decade.
New research by the University of Bristol highlights how the COVID-19 pandemic affected elective surgery in children with congenital heart disease
During the COVID-19 pandemic, healthcare...
A recent systematic review led by researchers from Santa Catarina State University (UDESC) in Brazil has revealed the connection between physical activity (PA) and sleep quality in older adults who experienced social isolation during the COVID-19 pandemic.
Pandemic preparedness has become a global priority since COVID-19 and new diseases continue to emerge and old ones resurge; this continues to be a threat to public health and economic stability.
In the possible event of a pandemic, the UK has secured 5 million doses of an H5 influenza vaccine to stay one step ahead of the avian influenza virus.
Despite the significant disease burden, Myalgic encephalomyelitis (ME), previously known as chronic fatigue syndrome (CFS), lacks effective diagnostics and therapeutics. Emily Taylor, President and CEO of Solve M.E., explains why dedicated research for Infection-Associated Chronic Conditions and Illnesses (IACCIs) such as ME/CFS is vitally needed.
Pandemic preparedness: A new report has sounded the alarm on the urgent need to address global disparities and foster interdisciplinary cooperation to effectively prepare for and respond to future pandemics.
The COVID-19 pandemic not only posed a public health crisis but also created cyber scam opportunities for cybercriminals to exploit the vulnerable in the rapidly changing digital environment.
In this exclusive, Ruth Richardson, Executive Director of the Accelerator for Systemic Risk Assessment (ASRA), calls on policymakers worldwide to transform risk management.
Researchers from the Wellcome Sanger Institute, University College London (UCL), and Imperial College London have revealed insights into why some people remain unscathed despite exposure to SARS-CoV-2, the virus responsible for COVID-19.
